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Abstract
Background: Sharing of microarray data within the research community has been greatly
facilitated by the development of the disclosure and communication standards MIAME and MAGE-
ML by the MGED Society. However, the complexity of the MAGE-ML format has made its use
impractical for laboratories lacking dedicated bioinformatics support.
Results: We propose a simple tab-delimited, spreadsheet-based format, MAGE-TAB, which will
become a part of the MAGE microarray data standard and can be used for annotating and
communicating microarray data in a MIAME compliant fashion.
Conclusion: MAGE-TAB will enable laboratories without bioinformatics experience or support
to manage, exchange and submit well-annotated microarray data in a standard format using a
spreadsheet. The MAGE-TAB format is self-contained, and does not require an understanding of
MAGE-ML or XML.
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Introduction
Sharing of microarray data within the research commu-
nity has been greatly facilitated by the development of dis-
closure and communication standards. The introduction
of the Minimum Information About a Microarray Experi-
ment (MIAME) standard [1] has been a great success,
while the development of a common data representation
format (MicroArray Gene Expression Mark-up Language
(MAGE-ML), [2]) has enabled researchers to exchange
data between laboratories and with public repository
databases. However, the complexity of the MAGE-ML for-
mat has made its use impractical for laboratories lacking
dedicated bioinformatics support. To address these needs,
we propose a simple spreadsheet-based format for repre-
senting primary data and experimental details (metadata)
from microarray investigations. We refer to this format as
MAGE-TAB (MicroArray Gene Expression Tabular). Using
MAGE-TAB, investigation design, array descriptions, and
processed data are described by using tab-delimited files,
or spreadsheets in the broad sense of the word. Addition-
ally, the raw data, such as Affymetrix CEL or GenePix GPR
files, can be provided in their native formats. Protocols are
described using free text. Documents in this format can be
created, viewed and edited in essentially any spreadsheet
software (e.g. Microsoft Excel), which is typically familiar
to biologists, who commonly use spreadsheets to main-
tain notes and track data. MAGE-TAB is designed for data
collection and annotation, as well as for data communica-
tion between tools and databases, including submissions
to public repositories.
One of the central concepts this paper will use to illustrate
the proposed format is the investigation design graph (IDG).
This IDG is a directed acyclic graph (DAG) representing
relationships between samples (or more generally materi-
als used in the investigation), arrays and data objects. An
example of such a graph describing a simple one-channel
microarray investigation is shown in Figure 1.
The information in this graph can be represented using a
spreadsheet (or more generally a tab-delimited text file) in
a simple and natural way, as shown in Table 1.
Although the example in Figure 1 and Table 1 relates to a
one-channel experiment, two-channel experiments can be
represented similarly, as demonstrated in the Implemen-
tation section below. The following principles guided the
design of the MAGE-TAB format:
An example of an investigation design graph for a simple one-channel array experimentFigure 1
An example of an investigation design graph for a simple one-channel array experiment. Three samples are used: 
liver, kidney, and brain. Labeled RNA extracts from each sample are hybridized on an array (type HG_U95A). The RNA 
extraction and labeling are described in the Material processing protocol, P-XMPL-1. Raw data files (Data1.cel, Data2.cel and 
Data3.cel) are obtained, and then normalized and summarized as described in the Normalization protocol, P-XMPL-2, generat-
ing the file FGDM.txt.Page 2 of 18
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BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/4891. The format should be simple, but should also provide
an explicit, structured representation of the details
required by the MIAME standard.
2. The format should support concise description of the
most frequently used experimental designs in a fashion
familiar to biologists.
3. It should be possible to easily create, read, understand
and edit documents in this format using only commonly
available tools, and requiring no special training in bioin-
formatics or computer programming.
4. The format should have a formal definition, it should
be machine-readable to the level of granularity defined by
the MIAME structure, and it should be usable for commu-
nicating microarray data between different databases, data
analysis tools and other software packages.
5. The formal definition should be based on the MAGE
object model and for documents that can be expressed in
MAGE-TAB there is a unique mapping to and from
MAGE-ML. At the same time no general MAGE knowledge
should be needed to use MAGE-TAB format.
The MAGE-TAB specification defines four different types
of files to fully describe a microarray investigation:
1. Investigation Description Format (IDF) – a tab-delim-
ited file providing general information about the investi-
gation, including its name, a brief description, the
investigator's contact details, bibliographic references,
and free text descriptions of the protocols used in the
investigation.
2. Array Design Format (ADF) – a tab-delimited file defin-
ing each array type used. An ADF file describes the design
of an array, e.g., what sequence is located at each position
on an array and what the annotation of this sequence is.
If the investigation uses arrays for which a description has
been previously provided, cross-references to entries in a
public repository (e.g., an ArrayExpress accession number
[3]) can be included instead of explicit array descriptions.
3. Sample and Data Relationship Format (SDRF) – a tab-
delimited file (or files) describing the relationships
between samples, arrays, data, and other objects used or
produced in the investigation, and providing all MIAME
information that is not provided elsewhere. This is often
the least trivial part of the experiment description due to
the complex relationships which are possible between
samples and their respective hybridizations; however, for
simple experimental designs, constructing the SDRF file is
straightforward, and even complex loop designs can be
expressed in this format.
4. Raw and processed data files – ASCII or binary files, typ-
ically in their native formats; alternatively, data may also
be provided in a specially defined tab-delimited format
termed a "data matrix", described below.
Background and rationale
Microarray investigations can be interpreted only in the
context of the experimental conditions under which the
samples used in each hybridization were generated. More-
over, microarray data are highly dependent on the partic-
ular experimental and data processing protocols. This
makes the use of microarray data considerably more com-
plicated than, for instance, genome sequence data, and
was the primary motivation for the development of the
MIAME standard by the Microarray Gene Expression Data
(MGED) Society [1]. As the title suggests, MIAME
describes the data and metadata that authors must pro-
vide to support conclusions drawn from a microarray
investigation, so that the data obtained in the investiga-
tion can be interpreted unambiguously and the investiga-
tion can be reproduced. The MIAME concept has been
highly successful. It has not only guided the development
of many software tools and databases, but has also been
accepted by most of the major scientific journals as a
means of making microarray data reported in publica-
tions available for scrutiny and for secondary analysis [4].
Table 1: A spreadsheet representation of the investigation design graph shown in Figure 1. 
Sample ID Characteristics
[Organism]
Characteristics
[OrganismPart]
Protocol
REF
Hybridization
ID
ArrayDesign
REF
ArrayData
URI
Protocol
REF
DerivedArrayData
Matrix URI
liver 1 Homo sapiens liver P-XMPL-1 hyb 1 HG_U95A Data1.cel P-XMPL-2 FGDM.txt
kidney 1 Homo sapiens kidney P-XMPL-1 hyb 2 HG_U95A Data2.cel P-XMPL-2 FGDM.txt
brain 1 Homo sapiens brain P-XMPL-1 hyb 3 HG_U95A Data3.cel P-XMPL-2 FGDM.txt
Each initial sample has a Sample ID (the first column in the spreadsheet) and Characteristics – Organism (genus and species) and OrganismPart (the 
second and third columns). The terms used to annotate the characteristics can be obtained from the MGED Ontology [26], another suitable source 
of controlled vocabulary terms, or provided as user defined terms. The fourth column gives a reference to a relevant protocol, while the fifth gives 
the IDs of the three hybridizations performed. The reference to the array design type (HG_U95A) is given as a hybridization property, which is 
followed by the data file names, a reference to the data normalization protocol and the normalized data file.Page 3 of 18
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ant data release as a condition of publication [5] has cre-
ated a substantial data flow to public repositories. The two
major databases, Gene Expression Omnibus (GEO) [6]
and ArrayExpress [3], now house more than 150,000
hybridization experiments, representing over 5,000 inves-
tigations.
The main goal of MIAME is to make these data as useful
as possible. MIAME provides the conceptual structure for
the representation of microarray data including:
1. general information about the investigation and its
design;
2. designs of the arrays used in the investigation;
3. characteristics of the samples used in the investigation;
4. experimental and data processing protocols;
5. raw and processed (normalized, filtered and/or
selected) data.
An important concept in MIAME is that of the experiment
or investigation design – the description of the relationships
between different samples, arrays to which they have been
hybridized, and the resulting data. Another important
concept is that of experimental factors, such as time, dose,
compound, or cell type. Experimental factors are typically
the variables of interest in the investigation. Experimental
factors enable the concise annotation of data – each col-
umn in the final data matrix can be annotated by the val-
ues of the most important factors characterizing the
particular experimental conditions (e.g., the compound
and the dose in a dose-response investigation). Logically,
there may be one or more experimental factors per sam-
ple, where the samples for which all experimental factor
values are identical are replicates. For more information
about MIAME see [7].
Although MIAME identifies the details necessary to
describe a microarray investigation, it does not provide a
precisely defined format for data representation. Such a
format is needed to cope with the growing flood of micro-
array data, and to facilitate automated communication
between different microarray laboratory information
management systems (LIMS), databases and data analysis
tools. MAGE-ML was proposed by MGED in 2002 [2] and
accepted as the Gene Expression specification standard by
the Object Management Group [8]. It has been successful
in that it has provided a platform for bioinformaticians
and software engineers to understand and communicate
information about high-throughput experiments in a pre-
cise language [9]. Moreover, many tools and databases
have implemented MAGE-ML either fully or in part (e.g.,
[10-14]). Data generated by more than 20 different tools,
representing more than 20,000 hybridizations, have been
provided in the MAGE-ML format and deposited in
ArrayExpress, and several fully automated data deposition
pipelines have been established in both public and private
organizations (e.g., [11])
MAGE-ML was the first nontrivial format developed for
communicating high-throughput functional genomics
experiment descriptions, and was developed at the same
time as the community was first attempting the large-scale
interchange of these functional genomic data. Neverthe-
less, MAGE-ML has not been accepted universally, for sev-
eral reasons. One shortcoming is that MAGE-ML is
ambiguous in that it permits encoding of the same seman-
tic information in different ways (this was later addressed
by developing the best practice 'How to encode MIAME in
MAGE' document [15]). However, the main drawback has
been the complexity of the MAGE-ML files, making it dif-
ficult to interpret or produce MAGE-ML files in the
absence of a dedicated software development effort,
which is seldom available for all but the largest laborato-
ries.
In addition to MAGE-ML and MAGE-TAB, there are other
specifications that support MIAME-compliant microarray
data. From a repository perspective the most popular are
the tab-delimited SOFT and the more recently introduced
XML-based MINiML. These formats were introduced by
GEO [6] and are designed to offer MIAME-capable data
encoding with little object modeling expense. They are
MIAME-supportive in the sense that they allow required
information to be represented as free text descriptions.
Free text is a powerful, highly flexible means for represent-
ing any information, but extracting the desired informa-
tion – such as experimental factors and their values – may
require some text mining. MINiML does not support
structured, machine-parseable encoding of investigation
design at the level of granularity required by MIAME; fur-
thermore, the included free text descriptions are difficult
to check for MIAME compliance, and not easily used in
computation.
We believe that there is a need for a MIAME supportive
format that is more structured than SOFT or MINiML, but
offers a less complex implementation than MAGE-ML.
With support from the National Human Genome
Research Institute (NHGRI) and the National Institute of
Biomedical Imaging and Bioengineering (NIBIB), the
MGED members are developing the next generation
microarray data standard, MAGE version 2 (MAGEv2
[16]). It has been proposed that MAGEv2 should consist
of several inclusive layers of increasing complexity, where
simple cases can be represented by simple constructs. ThePage 4 of 18
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layer of MAGEv2, and will be a sufficiently explicit, struc-
tured representation of information required by MIAME
for almost all types of investigations. Although MAGE-
TAB will be part of MAGEv2, it is important to note that
no knowledge of object modeling is required to use
MAGE-TAB and a substantially smaller set of documenta-
tion is necessary to learn MAGE-TAB.
Implementation
Investigation design graphs and their representations
A key recommendation of the MIAME standard is the
description of how biomaterials and data objects relate to
each other within an experiment. Such relationships are
most easily represented in graph form. A DAG in which
nodes represent biomaterials (e.g., samples, RNA extracts,
arrays) or data objects, and in which edges represent the
relationships between these objects, can be represented as
an IDG. For instance, an IDG can show which samples are
hybridized on which array, producing which data files, as
shown in Figure 2.
Nodes and edges in this graph can be annotated with
information about the respective objects, such as sample
characteristics. Edges (the relationships between nodes)
can be annotated by pointers to the respective experimen-
tal or data processing protocols, or by protocol parameters
(e.g., dyes Cy3 or Cy5 for labeling protocols). More com-
plex investigation design graphs are shown in Figures 1
and 3. The IDG is a general concept applicable to any
investigation description, and not restricted to microarray
investigations. Effectively, the IDG represents the work-
flow of the investigation. The level of detail in this work-
flow description can vary; here we aim at the level of detail
corresponding to the MIAME requirements. Two basic
notions we use in defining the IDG are biomaterial and
data object. The first intuitively represents a physical mate-
rial such as a sample, RNA extract, array, or hybridized
array. A protocol, when applied to a biomaterial, can gen-
erate a new biomaterial as its result. Biomaterials can also
be split or pooled. For instance, one can take two samples,
apply an RNA extraction/labeling protocol to each of
them, labeling with Cy3 in the first case and with Cy5 in
the second case, mix them and hybridize them on the
array (as shown in Figure 2). Data objects can be created
from biomaterials by applying a 'measurement' protocol,
for example, by scanning a hybridized array to obtain fea-
ture intensities. Data objects can be transformed into new
data objects by applying a data transformation protocol;
for precise definitions of these objects MAGE-TAB will
refer to the Functional Genomics Experiment (FuGE,
[17,18]) object model that provides a higher-level class
model for extension by technology-specific models such
as MAGEv2 [16].
Each node in an IDG has an identifier and a list of labels.
For instance, a node corresponding to a sample has the
sample identifier and the sample properties, e.g., 'Organ-
ism' (genus and species) and 'OrganismPart' (organ). A
label can be either a simple character string or a reference
to an external object such as an ontology entry. For
instance, 'Organism' will normally be described by an
external ontology (e.g., NCBI taxonomy), 'OrganismPart'
can be either a character string or an ontology entry
obtained from an anatomy source of controlled terms.
Edges in this graph can be labeled by protocols (or more
usually by references to protocols) that have been used to
derive one biomaterial from another. If protocols have
parameters, these parameter values can be shown as labels
on the respective edges (e.g., labeling protocols may have
'label' parameters, which can take values such as Cy3 or
Cy5). Finally, each node in the graph has a type, e.g., 'sam-
ple', 'extract', 'hybridization', 'data'.
A question arises: How granular should the graph be? For
instance, should one represent samples, extracts and
An example investigation design graphFigure 2
An example investigation design graph. This graph depicts two samples hybridized on an array (design name SMD-10K) 
labeled by Cy3 and Cy5, generating the data file Data.txt.Page 5 of 18
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ferent nodes? Note the differences between IDGs in Fig-
ures 1 and 3 – Figure 3 illustrates a two-channel
experiment comparing a series of RNA extracts with a
common reference extract, while Figure 1 represents a
much simpler single-channel experiment. An additional
layer of 'Extract' nodes have been used in Figure 3 to better
indicate the point at which pooling occurred. In practice,
the degree of granularity used in the IDG largely does not
matter, unless one of the 'intermediate' objects is being
split or pooled. Nodes in the graph that have only one
incoming and one outgoing edge can be contracted into
their predecessor nodes, by adding extra labels. Thus,
unless extracts are pooled or split, it is sufficient to show
which sample is hybridized to which array. Viewing a
complex investigation design as a graph may be helpful,
even if the graph is not drawn at the most granular scale
possible. The graph representation makes the replicate
structure in the investigation clear, and is even more valu-
able for developing software for data export/import from
a database or tool. The possibility to represent an investi-
gation design graph at different levels of granularity may
seem to introduce ambiguity. However, the investigation
design graph is an informal concept, and it is neither pos-
sible nor desirable to prescribe exactly how a particular
investigation should be represented. For our purposes, the
general guideline is that the graph should reflect the level
of granularity defined by MIAME. We will show in the
next section that this flexibility in the representation of an
IDG does not substantially affect the investigation design
representations in the resulting spreadsheets, as all these
different graphs will result in essentially the same spread-
sheet and encode the same semantic information. A
labeled graph can be encoded in various ways; in MAGE-
TAB, we use a tabular format for the following four rea-
sons:
An investigation design graph representing a two-channel experiment with extract pooling and reference RNAFigur  3
An investigation design graph representing a two-channel experiment with extract pooling and reference 
RNA. This investigation is similar to the example in the Introduction (Figure 1), except that it uses a two-channel array and an 
RNA reference. The extract pooling protocol has been omitted for clarity.Page 6 of 18
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cally have a regular structure, i.e., the same sub-graph is
repeated many times (possibly with well defined modifi-
cations); moreover, the replicated structure is simple. This
observation was supported by analysis of the structure of
over 1,000 different investigations in the ArrayExpress
database.
2. The degree of nodes in these graphs (i.e., the number of
incoming and outgoing edges for a node), is small (most
often 1 to 3), except for a few specific nodes which are
related 'reference' samples or extracts (e.g., 'Extract refer-
ence' in Figure 3).
3. The observation that DAGs which correspond to com-
monly used investigation designs have a property that
their nodes can be grouped in consecutive layers, i.e., the
source nodes (the nodes in the DAG which do not have
entering edges) are in layer 1, the nodes that are connected
to source nodes by an edge are in layer 2, etc. Furthermore,
the grouping can be done so that each layer only contains
objects of the same type, e.g., for the graph in Figure 3, we
have sample layer 1, extract layer 2, hybridization layer 3,
raw data file layer 4, and processed data layer 5.
4. Similar tabular formats have been used successfully in
the biosciences and are familiar to many practitioners. For
examples, see [19] for a spreadsheet approach to micro-
array data management, or [20], which describes the
application of spreadsheets to the problem of data acqui-
sition in the field of biochemical network modeling. In
addition, the PRIDE database [21] is also developing a
spreadsheet-based system for the submission of mass
spectrometry data.
Once a DAG of a regular structure has been represented in
such a layered fashion, it is natural to encode it as a tab-
delimited file or 'spreadsheet'. Each node in a DAG is rep-
resented by entries in a contiguous set of columns within
the spreadsheet. The first column within each set contains
the ID of the node, with subsequent columns containing
the labels attached to that node, followed by the labels of
the edges leading from the node. Note that the labels in
each list have a particular order. Objects of the same type
(e.g., Sample, Hybridization, ArrayData) are all contained
within the same column set, thereby capturing the layered
DAG structure within the spreadsheet. Each row in the
spreadsheet corresponds to a path in the graph from one
of the source nodes to one of the 'sink' nodes. Thus if there
are two or more edges leaving or entering a node, this
node will appear in the spreadsheet once for each path
passing through it. For instance, the DAG given in Figure
3 is represented as a spreadsheet in Table 2.
Note that use of IDGs provides a powerful mechanism to
describe the pooling or replicate structure of the investiga-
tion precisely and unambiguously. One can easily distin-
guish between biological replicates (different source
nodes, but all having the same experimental factor values;
see below for experimental factor definition) and techni-
cal replicates on various levels, such as several samples
from the same source, or dye swaps (Figure 5).
MAGE-TAB definition and examples
As described in the Introduction, a MAGE-TAB document
includes four different types of files: (1) Investigation
Description Format (IDF); (2) Array Design Format
(ADF); (3) Sample and Data Relationship Format (SDRF);
and (4) raw and processed data files. In this section we
will describe each of these in more detail. Here we
describe the main concepts and ideas upon which the for-
mat is based; the full MAGE-TAB specification is available
online [22].
Investigation Design Format
An overall description of an investigation, including pro-
tocols and contact details, consists of a relatively small
amount of information with few or no repetitious ele-
ments, and fits naturally into a single top-level document.
Table 3 shows an example of an IDF document. Values for
certain fields such as "Replicate Types" and "Protocol
Type" may be drawn from the MGED Ontology [23] pro-
viding for a shared vocabulary of terms across files. Where
fields may contain more than one term, these terms are
separated using a semicolon delimiter.
Array Design Format
The aim of the ADF component is to describe an array
design in a spreadsheet or a set of spreadsheets. Concep-
tually, microarray designs are devised to measure presence
and/or abundance of molecular (biosequence) entities in
biological samples. Each sequence of interest is repre-
sented by one or more reporter sequences on the array,
each of which in turn is present in one or more physical
locations on the two-dimensional microarray surface.
Thus three levels of hierarchy are required to describe the
array design:
1. A feature on the array – a location (spot) on the array
where nucleic acids are spotted or synthesized.
2. A reporter sequence – the sequence of the molecules
present at a particular feature on the array. Note that the
same reporter sequence can be present at different fea-
tures, i.e., there is one-to-many relationship between
reporter sequences and features.Page 7 of 18
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Table 2: SDRF representation of the investigation design graph in Figure 3. 
Sample ID Characteristics
[Organism]
Characteristics
[OrganismPart]
Protocol
REF
Extract ID Protocol
REF
Label Hybridization
ID
ArrayDesign 
REF
ArrayData
URI
DerivedArrayD
ata Matrix URI
liver 1 Homo sapiens liver P-XMPL-1 Extract 1 P-XMPL-3 Cy3 Hyb 1 SMD-10K 1.txt FGDM.txt
liver 2 Homo sapiens liver P-XMPL-1 Extract 2 P-XMPL-3 Cy3 Hyb 1 SMD-10K 1.txt FGDM.txt
kidney 1 Homo sapiens kidney P-XMPL-1 Extract 3 P-XMPL-3 Cy3 Hyb 2 SMD-10K 2.txt FGDM.txt
kidney 2 Homo sapiens kidney P-XMPL-1 Extract 4 P-XMPL-3 Cy3 Hyb 2 SMD-10K 2.txt FGDM.txt
brain 1 Homo sapiens brain P-XMPL-1 Extract 5 P-XMPL-3 Cy3 Hyb 3 SMD-10K 3.txt FGDM.txt
brain 2 Homo sapiens brain P-XMPL-1 Extract 6 P-XMPL-3 Cy3 Hyb 3 SMD-10K 3.txt FGDM.txt
Extract reference P-XMPL-3 Cy5 Hyb 1 SMD-10K 1.txt FGDM.txt
Extract reference P-XMPL-3 Cy5 Hyb 2 SMD-10K 2.txt FGDM.txt
Extract reference P-XMPL-3 Cy5 Hyb 3 SMD-10K 3.txt FGDM.txt
Each 'layer' in the graph is represented by an ID column in the spreadsheet, followed by columns for each of the labels. Each path in the graph is represented by one row in the spreadsheet.
BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/4893. A composite element – a set of reporter sequences
designed to measure the same biological entity, such as a
gene or an exon.
In the simplest case there may be a one-to-one relation-
ship between reporter sequences and the biological
objects they are measuring. However, in a more general
case, there may be a set of reporters measuring the biolog-
ical entity. For instance, on short oligonucleotide arrays
(such as those produced by Affymetrix), many reporters
are used to measure the expression of the same gene. In
the most general case there may be a many-to-many rela-
tionship between the reporters and the biological entities
they are measuring (for instance, the same short oligonu-
cleotide may be present in several different splice variants
of a gene). These concepts are derived from the MAGE
object model. To describe a microarray layout fully, infor-
mation about composite elements, reporter sequences,
and features on the array, and the relationships (map-
pings) between them, must be provided. The ADF has
been designed to provide the means to do this. An exam-
ple of an ADF document is shown in Table 4.
Sample and Data Relationship Format
The least trivial part of an investigation description is in
the relationship between sample and data objects, as rep-
resented in the SDRF file. As already mentioned, an inves-
tigation design can be described as a DAG, and the SDRF
is a spreadsheet-based representation of such graphs.
Tables 1 and 2 show SDRF examples representing the
investigation design graphs shown in Figures 1 and 3,
respectively. Similarly, Figure 4 shows a simplified exper-
imental design graph of replicated design, dual channel
with dye swap (the protocols and data files are omitted for
simplicity), and its spreadsheet representation is shown in
Table 5. In the next example (Figure 5), Sources are split
into Samples, which are then pooled into Extracts as
shown. The IDG in Figure 5 can be represented by the
SDRF in Table 6.
There are several conventions that can be used to make the
encoding of DAGs into spreadsheets more concise. First,
not every path in a DAG has to be represented on the
spreadsheet to encode the DAG unambiguously; it is suf-
ficient to represent every edge only once. For instance, in
Replicated design, dual channel with dye swapFigure 4
Replicated design, dual channel with dye swap. Data objects are not shown as there is a simple one-to-one mapping 
between hybridizations and raw data files.Page 9 of 18
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An example of a more complex experimental design (data objects not shown)Figure 5
An example of a more complex experimental design (data objects not shown). This is a real-world example, corre-
sponding to the experiment with accession number E-MIMR-12 in Array Express.
BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/489
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Table 3: An example of an IDF.
Investigation Title University of Heidelberg H sapiens TK6
Experimental Designs genetic_modification_design time_series_design
Experimental Factors GeneticModification Time
Person Last Name Maier Fleckenstein Li
Person First Name Patrick Katharina Li
Person Email patrick.maier@radonk.ma.uni-heidelberg.de
Person Phone +496213833773
Person Address Theodor-Kutzer-Ufer 1–3
Person Affiliation Department of Radiation Oncology, University 
of Heidelberg
Person Roles submitter; investigator investigator investigator
Quality Control Types biological_replicate
Replicate Types biological_replicate
Date of Experiment 2005-02-28
Public Release Date 2006-01-03
PubMed ID 12345678
Publication Author List Patrick Maier; Katharina Fleckenstein; Li Li; 
Stephanie Laufs; Jens Zeller; Stefan Fruehauf; 
Carsten Herskind; Frederik Wenz
Publication Status submitted
Experiment Description Gene expression of TK6 cells transduced with 
an oncoretrovirus expressing MDR1 
(TK6MDR1) was compared to untransduced 
TK6 cells and to TK6 cell transduced with an 
oncoretrovirus expressing the Neomycin 
resistance gene (TK6neo). Two biological 
replicates of each were generated and the 
expression profiles were determined using 
Affymetrix Human Genome U133 Plus2.0 
GeneChip microarrays. Comparisons between 
the sample groups allow the identification of 
genes with expression dependent on the 
MDR1 overexpression.
Protocol Name GROWTHPRTCL10653 EXTPRTCL10654 TRANPRTCL10656
Protocol Type grow nucleic_acid_extraction bioassay_data_transfor
mation
Protocol Description TK6 cells were grown in suspension cultures 
in RPMI 1640 medium supplemented with 10% 
horse serum (Invitrogen, Karlsruhe, Germany). 
The cells were routinely maintained at 37 C 
and 5% CO2.
Approximately 10 cells were lysed 
in RLT buffer (Qiagen).Total RNA 
was extracted from the cell lysate 
using an RNeasy kit (Qiagen).
Mixed Model 
Normalization with 
SAS Micro Array 
Solutions (version 1.3).
Protocol Parameters media Extracted Product; Amplification
SDRF Files e-mexp-428_tab.txt
Database CTO MO nci_meta
Database URI http://obo.sourceforge.net/cgi-bin/
detail.cgi?cell
http://mged.sourceforge.net/
ontologies/MGEDontology.php
http://
ncimeta.nci.nih.gov/
indexMetaphrase.html
Database Version 1.3.0.1
The first column represents the qualifier name, while their values are given starting from column 2 (if the qualifier has two or more values, each is 
given in a separate column).
BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/489the graph shown in Figure 6, there are four possible paths
(a → c → d), (a → c → e), (b → c → d), and (b → c → e).
However, it is enough to present only two full paths, e.g.,
(a → c → d) and (b → c → e), to represent all the relation-
ships between the nodes in the graph, as shown in the
spreadsheet in Table 7. The second 'compaction' rule
allows an SDRF spreadsheet to be split vertically on any
ID column. More precisely, it is permitted to end an SDRF
table at any ID column, and then start a subsequent table
with the same column. It is not necessary to duplicate
lines for any ID in the second part. For instance, the SDRF
in Table 2 can be represented by the two spreadsheets in
Tables 8 and 9.
For a detailed description of rules for encoding an arbi-
trary investigation design graph as an SDRF file, see the
MAGE-TAB online documentation [22].
Data files
The MAGE-TAB specification requires that raw data files
are provided as binary or ASCII files in their native for-
mats, such as Affymetrix CEL files, Agilent TXT files, or
GenePix GPR files, whereas processed data files may be
communicated in tab-delimited text format as data matrix
files. Normally, a MAGE-TAB document will have one
data matrix where rows typically represent genes (though
they may also represent other biological entities, such as
exons or genomic locations), and columns typically repre-
sent samples or experimental conditions. One can think
of such a matrix as containing the data that are typically
published as supplementary information for a given
paper and on which the author would perform analyses
such as clustering.
The main feature of data matrices, that distinguishes them
from arbitrary data files, is that columns in such matrices
have references to ID objects in SDRF files, for instance to
particular raw data files or particular samples. This ena-
bles mapping from biomaterials and their characteristics
(especially experimental factor values) to individual proc-
essed data columns by following the edges in the investi-
gation design graph. Syntactically, each data matrix file
has two header rows, as shown in Table 10. The first
header row contains references to ID objects in an SDRF
file. All the IDs should come from one particular column
in the SDRF. That is, each column in the data matrix is
marked by unique IDs from a particular column in the
SDRF. The second row contains the names of the quanti-
tation types, such as 'signal', 'p-value', or 'log_ratio(Cy3/
Cy5)' (from the MAGE-TAB perspective, these are simply
labels that do not have to have a particular meaning, but
normally should be defined in the data processing proto-
col). An example is shown in Table 10.
Table 5: Replicated design, dual channel with dye swap. Data objects have been omitted for brevity.
Source ID Sample ID Extract ID LabeledExtract ID Label Hybridization ID
Source 1a Sample 1a Extract 1a LabeledExtract 1a Cy3 Cy3 Hybridization 1
Source 1b Sample 1b Extract 1b LabeledExtract 1b Cy5 Cy5 Hybridization 1
Source 1a Sample 1a Extract 1a LabeledExtract 1a Cy5 Cy5 Hybridization 2
Source 1b Sample 1b Extract 1b LabeledExtract 1b Cy3 Cy3 Hybridization 2
Source 2a Sample 2a Extract 2a LabeledExtract 2a Cy3 Cy3 Hybridization 3
Source 2b Sample 2b Extract 2b LabeledExtract 2b Cy5 Cy5 Hybridization 3
Source 2a Sample 2a Extract 2a LabeledExtract 2a Cy5 Cy5 Hybridization 4
Source 2b Sample 2b Extract 2b LabeledExtract 2b Cy3 Cy3 Hybridization 4
Table 4: An example of an ADF document. 
Block
Column
Block
Row
Column Row Reporter ID Reporter Sequence Reporter
Group
Control
Type
CompositeE
lement ID
1 1 1 1 R1 ATGGTTGGTTACGTGT experimental PTEN
1 1 1 2 R2 CCGCGTTGCCCCGCC experimental PAX2
1 1 1 3 R3 CGTAGCTGATCGATGA experimental WWOX
1 1 1 4 R4 GGTTGGCTGAGATCGT experimental MAPK8
1 1 2 1 R1 ATGGTTGGTTACGTGT experimental PTEN
1 1 2 2 R2 CCGCGTTGCCCCGCC experimental PAX2
1 1 2 3 R3 CGTAGCTGATCGATGA experimental WWOX
1 1 2 4 R4 GGTTGGCTGAGATCGT experimental MAPK8
... ... ... ... ... ... ... ... ...
4 6 20 20 462020 TCCCTTCCGTTGTCCT control control_spike_calibration
Note how the information about Reporter and CompositeElement is duplicated to indicate the fact that every synthetic sequence is spotted more 
than once on the array.Page 12 of 18
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matrix can be automatically and concisely annotated by
the most important characteristics, such as experimental
factor values (see next section).
Results and Discussion
Experimental factors and their values
Experimental factors and experimental factor values are
important concepts in MIAME. The experimental factors
are the principal variables in the investigation, for
instance "time" in time series investigations, "dose" in
dose response investigations, "compound" in compound
treatment investigations, or "disease state" (normal or
otherwise) in disease studies. The same investigation may
have several experimental factors; for example, com-
pound, dose and time may all be experimental factors in
a dose response investigation in which several com-
pounds are added to the samples over a time course.
Experimental factors and their values can appear in the
SDRF file in any column (Table 11), and are annotated as
such by being listed in the IDF file. For example, the IDF
linked to the SDRF in Table 11 would include the MGED
Ontology term "Time" in its list of experimental factors
(see Table 3), indicating that the "ParameterValue [Time]"
column represents an experimental variable. Biological
replicates are represented by distinct biological sources,
grouped together by common experimental factor values.
In contrast, technical replicates are represented by branch-
Table 6: Representation of the investigation design in Figure 5 as an SDRF. 
Source ID Sample ID Extract ID LabeledExtract ID Label Hybridization ID
BS_TKAC_13 BSM_TKAC_01m BSM_TKAC_22p BSM_TKAC_22p biotin HFB2002012101A
BS_TKAC_13 BSM_TKAC_02m BSM_TKAC_23p BSM_TKAC_23p biotin HFB2002012102A
BS_TKAC_13 BSM_TKAC_03m BSM_TKAC_24p BSM_TKAC_24p biotin HFB2002012103A
BS_TKAC_13 BSM_TKAC_04m BSM_TKAC_25p BSM_TKAC_25p biotin HFB2002012104A
BS_TKAC_13 BSM_TKAC_05m BSM_TKAC_26p BSM_TKAC_26p biotin HFB2002012105A
BS_TKAC_13 BSM_TKAC_06m BSM_TKAC_27p BSM_TKAC_27p biotin HFB2002012106A
BS_TKAC_13 BSM_TKAC_07m BSM_TKAC_28p BSM_TKAC_28p biotin HFB2002012107A
BS_TKAC_13 BSM_TKAC_08m BSM_TKAC_29p BSM_TKAC_29p biotin HFB2002012108A
BS_TKAC_13 BSM_TKAC_09m BSM_TKAC_30p BSM_TKAC_30p biotin HFB2002012109A
BS_TKAC_13 BSM_TKAC-10m BSM_TKAC_31p BSM_TKAC_31p biotin HFB2002012110A
BS_TKAC_14 BSM_TKAC_01n BSM_TKAC_22p BSM_TKAC_22p biotin HFB2002012101A
BS_TKAC_14 BSM_TKAC_02n BSM_TKAC_23p BSM_TKAC_23p biotin HFB2002012102A
BS_TKAC_14 BSM_TKAC_03n BSM_TKAC_24p BSM_TKAC_24p biotin HFB2002012103A
BS_TKAC_14 BSM_TKAC_04n BSM_TKAC_25p BSM_TKAC_25p biotin HFB2002012104A
BS_TKAC_14 BSM_TKAC_05n BSM_TKAC_26p BSM_TKAC_26p biotin HFB2002012105A
BS_TKAC_14 BSM_TKAC_06n BSM_TKAC_27p BSM_TKAC_27p biotin HFB2002012106A
BS_TKAC_14 BSM_TKAC_07n BSM_TKAC_28p BSM_TKAC_28p biotin HFB2002012107A
BS_TKAC_14 BSM_TKAC_08n BSM_TKAC_29p BSM_TKAC_29p biotin HFB2002012108A
BS_TKAC_14 BSM_TKAC_09n BSM_TKAC_30p BSM_TKAC_30p biotin HFB2002012109A
BS_TKAC_14 BSM_TKAC-10n BSM_TKAC_31p BSM_TKAC_31p biotin HFB2002012110A
BS_TKAC_15 BSM_TKAC_01o BSM_TKAC_22p BSM_TKAC_22p biotin HFB2002012101A
BS_TKAC_15 BSM_TKAC_02o BSM_TKAC_23p BSM_TKAC_23p biotin HFB2002012102A
BS_TKAC_15 BSM_TKAC_03o BSM_TKAC_24p BSM_TKAC_24p biotin HFB2002012103A
BS_TKAC_15 BSM_TKAC_04o BSM_TKAC_25p BSM_TKAC_25p biotin HFB2002012104A
BS_TKAC_15 BSM_TKAC_05o BSM_TKAC_26p BSM_TKAC_26p biotin HFB2002012105A
BS_TKAC_15 BSM_TKAC_06o BSM_TKAC_27p BSM_TKAC_27p biotin HFB2002012106A
BS_TKAC_15 BSM_TKAC_07o BSM_TKAC_28p BSM_TKAC_28p biotin HFB2002012107A
BS_TKAC_15 BSM_TKAC_08o BSM_TKAC_29p BSM_TKAC_29p biotin HFB2002012108A
BS_TKAC_15 BSM_TKAC_09o BSM_TKAC_30p BSM_TKAC_30p biotin HFB2002012109A
BS_TKAC_15 BSM_TKAC_10o BSM_TKAC_31p BSM_TKAC_31p biotin HFB2002012110A
BS_TKAC_16 BSM_TKAC_01q BSM_TKAC_22p BSM_TKAC_22p biotin HFB2002012101A
BS_TKAC_16 BSM_TKAC_02q BSM_TKAC_23p BSM_TKAC_23p biotin HFB2002012102A
BS_TKAC_16 BSM_TKAC_03q BSM_TKAC_24p BSM_TKAC_24p biotin HFB2002012103A
BS_TKAC_16 BSM_TKAC_04q BSM_TKAC_25p BSM_TKAC_25p biotin HFB2002012104A
BS_TKAC_16 BSM_TKAC_05q BSM_TKAC_26p BSM_TKAC_26p biotin HFB2002012105A
BS_TKAC_16 BSM_TKAC_06q BSM_TKAC_27p BSM_TKAC_27p biotin HFB2002012106A
BS_TKAC_16 BSM_TKAC_07q BSM_TKAC_28p BSM_TKAC_28p biotin HFB2002012107A
BS_TKAC_16 BSM_TKAC_08q BSM_TKAC_29p BSM_TKAC_29p biotin HFB2002012108A
BS_TKAC_16 BSM_TKAC_09q BSM_TKAC_30p BSM_TKAC_30p biotin HFB2002012109A
BS_TKAC_16 BSM_TKAC_10q BSM_TKAC_31p BSM_TKAC_31p biotin HFB2002012110A
The bold highlighting indicates the materials linked to a single hybridization for ease of viewing this example.Page 13 of 18
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BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/489ing of the investigation design graph at intermediate steps
of the experimental processing.
The experimental factor values are the values of the respec-
tive experimental factors in a particular sample. For
instance, in a time series the values are the time points at
which each measurement was taken.
Experimental factor values provide a means of annotating
investigations concisely – the most important experimen-
tal variables are clearly and accessibly defined. Moreover,
one can easily represent biological replicates: these are
samples which have different sources, but exactly the
same values for all experimental factors. By propagating
the factor values down to data columns in the processed
data, one can annotate data concisely. For instance, if we
have two experimental factors compound and dose, each
of which have two possible values, e.g. compounds c1 and
c2, and low dose and high dose, then the data columns
will be annotated by combinations of these values: (c1,
low), (c2, low), (c1, high), (c2, high).
Applications of MAGE-TAB
MAGE-TAB can be used in either of two ways:
1. Creating MAGE-TAB documents using spreadsheet tem-
plates provided in the main specification document [22]
or creating them 'from scratch';
2. Developing MAGE-TAB export or import functionality
for microarray databases or tools.
Details of the second use depend on the particular struc-
ture of the database or tool; as this is mostly aimed at soft-
ware developers and professional bioinformaticians it
will not be discussed here. The first approach may be used
by biologists to keep track of data, to submit the data to
either public or private repositories, or to exchange data.
Use of existing template SDRF documents can simplify
this approach. The MAGE-TAB specification document
provides templates for several 'standard' experimental
designs for one- and two-channel investigations includ-
ing:
1. simple replicated design;
2. replicated design with technical replicates;
3. replicated design with pooling;
4. replicated designs for dual channel investigations;
5. dual channel replicated designs with dye swap;
Table 7: SDRF representation of the DAG in Figure 6. 
Source layer Mid layer Sink layer
a c d
b c e
To describe the IDG in Figure 6, only two of the possible four paths 
need be shown; redundant edges in the graph may be omitted.
Graph with four possible paths between nodesFigure 6
Graph with four possible paths between nodes. While four paths are possible between the nodes in this graph [(a → c 
→ d), (a → c → e), (b → c → d), and (b → c → e)], only two full paths, e.g., (a → c → d) and (b → c → e), are required to 
capture all of the existing relationships between the nodes.Page 14 of 18
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ple;
7. dual channel replicated design with a reference and dye
swap;
8. dual channel replicated design with a pooled reference;
9. loop design;
10. loop design with dye swap;
11. time series investigations.
This list is by no means exhaustive; in fact, MAGE-TAB
does not prescribe any particular investigation design.
Rather, the purpose of this template collection is to help
users to create an SDRF file for their particular design. IDF
and ADF files are quite straightforward to create; moreo-
ver, for experiments that are done on standard arrays, such
as Affymetrix or Agilent, biologists do not need to create
the ADF files, as they are provided by the manufacturers
and public databases.
Conclusion
MAGE-TAB is designed to serve as a format for data collec-
tion, presentation, and communication. Some may argue
Table 10: An example of a data matrix. 
ArrayData REF Data1.cel Data1.cel Data2.cel Data2.cel Data3.cel Data3.cel
Reporter REF signal p-value signal p-value signal p-value
Gene 1 x11 p11 x21 p21 x31 p31
Gene 2 x12 p12 x22 p22 x32 p32
Gene 3 x13 p13 x23 p23 x33 p33
... ... ... ... ... ... ...
Gene n x1n p1n x2n p2n x3n p3n
The first row gives references to objects in an SDRF file, for instance to ArrayData URIs in the SDRF in Table 1. The second row specifies the 
names of the quantitation types that are represented in each column. The first column gives the names of the biological objects these 'expression' 
measurements relate to, for instance the IDs of the reporters or composite elements in the ADF file or files describing the design of array(s) on 
which these measurements have been performed. Alternatively, this column may contain identifiers from public sequence databases, or 
chromosome coordinates from a specified genome build.
Table 8: Representing SDRF from Table 2 by a set of two SDRF files: first spreadsheet. 
Sample ID Characteristics
[Organism]
Characteristics
[OrganismPart]
Protocol REF Extract ID Protocol REF Label Hybridization ID
liver 1 Homo sapiens liver P-XMPL-1 Extract 1 P-XMPL-3 Cy3 Hyb 1
liver 2 Homo sapiens liver P-XMPL-1 Extract 2 P-XMPL-3 Cy3 Hyb 1
kidney 1 Homo sapiens kidney P-XMPL-1 Extract 3 P-XMPL-3 Cy3 Hyb 2
kidney 2 Homo sapiens kidney P-XMPL-1 Extract 4 P-XMPL-3 Cy3 Hyb 2
brain 1 Homo sapiens brain P-XMPL-1 Extract 5 P-XMPL-3 Cy3 Hyb 3
brain 2 Homo sapiens brain P-XMPL-1 Extract 6 P-XMPL-3 Cy3 Hyb 3
Extract reference P-XMPL-3 Cy5 Hyb 1
Extract reference P-XMPL-3 Cy5 Hyb 2
Extract reference P-XMPL-3 Cy5 Hyb 3
Such splitting of an SDRF spreadsheet can be done on any ID column, which becomes the last column in the first spreadsheet (this table) and is 
repeated as the first column in the second spreadsheet (Table 9).
Table 9: Representing SDRF from Table 2 by a set of two SDRF files: second spreadsheet.
Hybridization ID ArrayDesign REF ArrayData URI DerivedArrayData Matrix URI
Hyb 1 SMD-10K 1.txt FGDM.txt
Hyb 2 SMD-10K 2.txt FGDM.txt
Hyb 3 SMD-10K 3.txt FGDM.txt
See the legend to Table 8 for discussion. Because each Hybridization ID only needs to be represented once, the second partial spreadsheet has 
three rows instead of nine (discounting the header row).Page 15 of 18
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Table 11: Experimental factor values example. The Characteristics categories used in column headings (i.e., the terms in square brackets) are taken from the MGED Ontology 
"BioMaterialCharacteristics" class [26]. The values contained in the body of these columns may be either free text, or terms from an ontology as indicated by an "OI" tag in the 
column heading (relating to the MAGEv2 concept "OntologyIndividual"). For example, the "OI:nci_meta" tag indicates that terms are taken from the NCI Metathesaurus [27]. The 
sources for these database tags ("nci_meta", "CTO") are defined in the IDF, as shown in Table 3. Biological replicates are indicated by shared experimental factor values ("Time" in 
this example; the columns containing experimental factors would be specified in the accompanying IDF). Most of the protocols have been omitted for brevity. Please see the detailed 
MAGE-TAB specification document [22] for more information.
Source
ID
Characteristics
[CellLine]
Characteristics
[CellType] OI:CTO
Characteristics [DiseaseState]
OI:nci_meta
Characteristics
[Organism]
OI:ncbitax
Protocol
REF
ParameterValue
[Time]
Unit
[TimeUnit]
OI:MO
Hybridization
ID
ArrayDesign
REF
ARP1-0h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 0 hours H_ARP1-0h A-AFFY-33
ARP2-0h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 0 hours H_ARP2-0h A-AFFY-33
ARP3-0h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 0 hours H_ARP3-0h A-AFFY-33
ARP1-2h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 2 hours H_ARP1-2h A-AFFY-33
ARP2-2h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 2 hours H_ARP2-2h A-AFFY-33
ARP3-2h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 2 hours H_ARP3-2h A-AFFY-33
ARP1-4h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 4 hours H_ARP1-4h A-AFFY-33
ARP2-4h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 4 hours H_ARP2-4h A-AFFY-33
ARP3-4h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 4 hours H_ARP3-4h A-AFFY-33
ARP1-6h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 6 hours H_ARP1-6h A-AFFY-33
ARP2-6h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 6 hours H_ARP2-6h A-AFFY-33
ARP3-6h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 6 hours H_ARP3-6h A-AFFY-33
ARP1-8h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 8 hours H_ARP1-8h A-AFFY-33
ARP2-8h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 8 hours H_ARP2-8h A-AFFY-33
ARP3-8h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 8 hours H_ARP3-8h A-AFFY-33
ARP1-10h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 10 hours H_ARP1-10h A-AFFY-33
ARP2-10h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 10 hours H_ARP2-10h A-AFFY-33
ARP3-10h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 10 hours H_ARP3-10h A-AFFY-33
ARP1-12h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 12 hours H_ARP1-12h A-AFFY-33
ARP2-12h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 12 hours H_ARP2-12h A-AFFY-33
ARP3-12h MOLT4 T cell acute lymphoblastic leukemia Homo sapiens P-XMPL-3 12 hours H_ARP3-12h A-AFFY-33
BMC Bioinformatics 2006, 7:489 http://www.biomedcentral.com/1471-2105/7/489that the data communication format should be separated
from the collection and presentation format, on the
grounds that the data communication format is designed
solely for computers, whereas data collection and presen-
tation depend upon human-computer interactions. This
convention has been used in MAGE-ML with some suc-
cess. However, the separation of these formats can only
work well if there are good tools to interconvert the data
collection and communication formats. Because tool
development has proven to be expensive and time con-
suming, a format that is simple enough to be usable with-
out any specialized tools is needed at present. MAGE-TAB
serves as such a format.
A valid caveat regarding spreadsheet-based formats relates
to the limitations of currently-available spreadsheet soft-
ware. At present, the maximum number of rows allowable
in a Microsoft Excel or OpenOffice spreadsheet is 65,536;
it is anticipated that many array designs will exceed this
number of features, rendering such software packages less
useful for constructing ADF files. In addition, these soft-
ware packages often implement automatic date format
and floating point conversions which can silently alter
values entered into a spreadsheet to render them invalid
[24]. Care must therefore be taken when using these pro-
grams, for instance by formatting the entire spreadsheet as
plain-text prior to entering any data. 
Some would argue that XML-based formats are more
appropriate for data exchange than tabular formats. How-
ever, this is not universally true – XML is most appropriate
for representing tree-like structures, whereas investigation
design graphs are DAGs. It can be quite cumbersome to
represent a DAG in an XML-based format. Our observa-
tion that the DAGs corresponding to investigation graphs
are regular, layered and have a small node degree (except
for the reference nodes), has enabled us to find a natural
way to represent such DAGs in a spreadsheet format. As
far as array designs are concerned, their representation as
spreadsheets is straightforward since such data are natu-
rally encoded in a tabular format. 
Moreover, since the level of granularity in MAGE-TAB is
consistent with that of MIAME, it also offers a formal
model for representing MIAME-compliant data that is
simpler than the full MAGE object model. We propose
that MAGE-TAB becomes a platform-specific implementa-
tion of the 'simple layer' of MAGE. As such, MAGE-TAB
will be more limited in expressivity than MAGE-ML. For
example, protocols are described as free text with optional
parameters, rather than as a series of discrete steps. 
The ArrayExpress database is planning to accept submis-
sions in the finalized MAGE-TAB format as soon as practi-
cally possible. In effect, a prototype called 'Tab2MAGE'
[25] which uses spreadsheets similar to the MAGE-TAB
format has already been implemented and proven to
work. (ArrayExpress will also continue to accept submis-
sions in MAGE-ML, and will accept MAGE-ML v2 when it
is available). ArrayExpress will also provide data export in
MAGE-TAB format. In the next 12–24 months we will
gather feedback on how well this format works in practice,
and make the necessary revisions, as part of the MAGEv2
development process. Nevertheless, we expect that the for-
mat will be stable, and even if some changes are needed in
the future, we aim to provide software for interconverting
the formats. 
In conclusion, we note that MAGE-TAB has been designed
to address the needs of the microarray community, by
providing a simple format for representing and communi-
cating MIAME-compliant data in a structured way with
minimal investment.
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